Home | Orthoiodosupplementation | Body | Disease | Special | Overviews

Iodine and the Body

Pregnancy

• Aghini-Lombardi
• Allen
• Ardawi
• Ares
• Bader
• Burrow
• Cao, DeLong, Jiang
• Chierici
• Delange
• de Luis
• Derry
• Dorea
• Dunn
• Eltom
• Fernandez-Soto
• Filetti
• Glinoer
• Haddow
• Jancin
• Koutras
• Kung
• Laurberg, Pedersen
• Lazarus
• Liesenkotter
• Mitchell
• Mahomed
• Moon
• Moscicka
• Nishiyama
• NRDC
• Papiernik
• Reinhardt
• Rogahn
• Seibold-Weiger
• Smyth
• Soldin
• Stulc
• Tsintsadze
• Vermiglio
• Williams
• Yang
• Zimmermann

Fernandez-Soto

Thyroid peroxidase autoantibodies predict poor metabolic control and need for thyroid treatment in pregnant IDDM women.

Fernandez-Soto L, Gonzalez A, Lobon JA, Lopez JA, Peterson CM, Escobar-Jimenez F.

Diabetes Care. 1997 Oct;20(10):1524-8.

[abstract only

"OBJECTIVE: To study whether the presence of antithyroid peroxidase antibodies (TPO-Abs) before gestation in IDDM affects thyroid function and metabolic control during pregnancy and early postpartum as well as neonatal outcome.

RESEARCH DESIGN AND METHODS: A prospective study at an outpatient endocrine-obstetric unit was carried out in 20 pregnant IDDM women. Free T4 (thyroxine), thyroid-stimulating hormone (TSH), TPO-Abs, and HbA1c were assayed before gestation; during the first, second, and third trimester of pregnancy; and 3 months postpartum.

RESULTS: HbA1c was significantly higher in TPO-Ab+ women than in those who were TPO-Ab- during the second (P < 0.01) and third (P < 0.05) trimesters. HbA1c levels significantly decreased in TPO-Ab- patients when the second (P < 0.01) and third (P < 0.05) trimesters were compared with before the pregnancy and the first trimester. There was a significant increase in the dosage of insulin for TPO-Ab+ versus TPO-Ab- patients during the second (P < 0.05) and third (P < 0.01) trimesters and 3 months postpartum (P < 0.05). TSH was significantly increased in the second (P < 0.001) and third (P < 0.05) trimesters and 3 months postpartum (P < 0.01) when compared with TPO-Ab- patients; 7.6% of the TPO-Ab- group and 29% in the TPO-Ab+ group presented postpartum thyroid dysfunction, and 42% of the TPO-Ab+ women required thyroid treatment.

CONCLUSIONS: Pregnant women with IDDM who have a positive test for TPO-Abs before gestation have poorer glucose control and a high prevalence of hypothyroidism. Therefore we recommend that prepregnant IDDM patients be screened for anti-TPO-Abs. Those with a positive result should be followed with serial monitoring of free T4 and TSH levels during each trimester as well as the postpartum period."
 

 Home | Orthoiodosupplementation | Body | Disease | Special Topics | Overviews  

The Iodine Group | Books | Disclaimers | Contact Us | Search  

  Copyright: Zoe, 2006.